Pfizer's CEO Salary
- A. Bourla Chairman and Chief Executive Officer at Pfizer, received a total compensation of $27.59 M in 2025.
- C. Boshoff Chief Scientific Officer and President, Research & Development at Pfizer, received a total compensation of $10.01 M in 2025.
- D. Denton Chief Financial Officer, EVP at Pfizer, received a total compensation of $9.67 M in 2025.
- A. Malik Chief U.S. Commercial Officer, EVP at Pfizer, received a total compensation of $9.43 M in 2025.
- D. Lankler Chief Legal Officer, EVP at Pfizer, received a total compensation of $9.11 M in 2025.
Pfizer's CEO salary and other executives compensation in 2025 was as follows:
Executive Compensation Summary Table
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| A. Bourla Chairman and Chief Executive Officer | $27.59 M | $24.65 M | $21.56 M |
| Base Salary | $1.80 M | $1.80 M | $1.79 M |
| Incentive Plan Compensation | $5.40 M | $7.02 M | - |
| All Other Compensation | $1.94 M | $996.06 K | $2.26 M |
| Stock Award | $9.44 M | $4.84 M | $8.75 M |
| C. Boshoff Chief Scientific Officer and President, Research & Development | $10.01 M | $7.85 M | - |
| Base Salary | $1.40 M | $1.20 M | - |
| Incentive Plan Compensation | $3.15 M | $2.88 M | - |
| All Other Compensation | $648.01 K | $627.83 K | - |
| Stock Award | $1.81 M | $896.30 K | - |
| D. Denton Chief Financial Officer, EVP | $9.67 M | $8.12 M | $5.28 M |
| Base Salary | $1.39 M | $1.35 M | $1.30 M |
| Incentive Plan Compensation | $2.80 M | $2.96 M | - |
| All Other Compensation | $613.84 K | $236.95 K | $451.16 K |
| Stock Award | $2.37 M | $1.13 M | $1.34 M |
| A. Malik Chief U.S. Commercial Officer, EVP | $9.43 M | $8.29 M | $5.42 M |
| Base Salary | $1.39 M | $1.34 M | $1.29 M |
| Incentive Plan Compensation | $2.90 M | $3.09 M | - |
| All Other Compensation | $611.25 K | $253.16 K | $599.26 K |
| Stock Award | $2.28 M | $1.13 M | $1.34 M |
| D. Lankler Chief Legal Officer, EVP | $9.11 M | $6.81 M | $5.48 M |
| Base Salary | $1.41 M | $1.24 M | $1.20 M |
| Incentive Plan Compensation | $2.68 M | $2.46 M | - |
| All Other Compensation | $535.59 K | $244.78 K | $561.89 K |
| Stock Award | $1.98 M | $913.35 K | $1.82 M |
| M. Dolsten Chief Scientific Officer, President, Pfizer Research Development | - | $9.74 M | $8.86 M |
| Base Salary | - | $1.65 M | $1.60 M |
| Incentive Plan Compensation | - | $2.90 M | - |
| All Other Compensation | - | $309.60 K | $812.40 K |
| Stock Award | - | $1.57 M | $3.12 M |
| C. Boshoff Chief Scientific Officer and President, Research Development | - | $7.85 M | - |
| Base Salary | - | $1.20 M | - |
| Incentive Plan Compensation | - | $2.88 M | - |
| All Other Compensation | - | $627.83 K | - |
| Stock Award | - | $896.30 K | - |
| A. Hwang Former Chief Commercial Officer and President, Global Biopharmaceuticals Business | - | - | $6.69 M |
| Base Salary | - | - | $1.34 M |
| Incentive Plan Compensation | - | - | - |
| All Other Compensation | - | - | - |
| Stock Award | - | - | $2.34 M |
| W. Pao Former Chief Development Officer, EVP | - | - | $6.25 M |
| Base Salary | - | - | $772.50 K |
| Incentive Plan Compensation | - | - | - |
| All Other Compensation | - | - | $2.51 M |
| Stock Award | - | - | $577.86 K |
| D. Lankler General Counsel, EVP | - | - | $3.02 M |
| Base Salary | - | - | $1.20 M |
| Incentive Plan Compensation | - | - | - |
| All Other Compensation | - | - | - |
| Stock Award | - | - | $1.82 M |
